Natural polymer hydrogels are used ubiquitously as scaffold materials for cardiac tissue engineering as well as for soft tissue engineering more broadly because of FDA approval, minimal immunogenicity, and well-defined physiological clearance pathways. However, the relationships between natural polymer hydrogels and resident cell populations in directing the development of engineered tissues are poorly defined. This interaction is of particular concern for tissues prepared with iPSC-derived cell populations, in which population purity and batch-to-batch variability become additional critical factors to consider. Herein, the design space for a blended fibrin and collagen scaffold is characterized for applications in creating engineered myoca...
Thesis (Ph.D.)--University of Washington, 2013Myocardial infarction (MI) causes significant cell los...
Tissue engineering approaches are currently being investigated for the restoration of myocardial fun...
Valvular heart disease is predicted to be the next cardiac epidemic (d’Arcy et al., 2011) and valve ...
Cardiac tissue engineering is a strategy to replace damaged contractile tissue and model cardiac dis...
Cardiovascular disease is the leading cause of death in the US, which can result in blockage of a co...
Human induced pluripotent stem cell derived cardiomyocytes (iPSC-CMs) are widely suggested as a suit...
Cardiomyocyte and stroma cell cross-talk is essential for the formation of collagen-based engineered...
Cardiac fibrosis is a disease state characterized by excessive collagenous matrix accumulation withi...
Background—In heart valve tissue engineering, the optimization of tissue properties has to be combin...
Maintenance of collagen I (Col I) and III (Col III) in a 3:1 ratio is necessary to promote cardiac h...
Maintenance of collagen I (Col I) and III (Col III) in a 3:1 ratio is necessary to promote cardiac h...
Cardiomyocytes derived from human embryonic stem cells (hESC-CMs) are regarded as promising cell sou...
The ideal scaffold for tissue engineering provides an architecture similar to natural tissue. For ca...
Activation of cardiac fibroblasts into myofibroblasts is considered to play an essential role in car...
In vitro maturation of cardiomyocytes in 3D is essential for the development of viable cardiac model...
Thesis (Ph.D.)--University of Washington, 2013Myocardial infarction (MI) causes significant cell los...
Tissue engineering approaches are currently being investigated for the restoration of myocardial fun...
Valvular heart disease is predicted to be the next cardiac epidemic (d’Arcy et al., 2011) and valve ...
Cardiac tissue engineering is a strategy to replace damaged contractile tissue and model cardiac dis...
Cardiovascular disease is the leading cause of death in the US, which can result in blockage of a co...
Human induced pluripotent stem cell derived cardiomyocytes (iPSC-CMs) are widely suggested as a suit...
Cardiomyocyte and stroma cell cross-talk is essential for the formation of collagen-based engineered...
Cardiac fibrosis is a disease state characterized by excessive collagenous matrix accumulation withi...
Background—In heart valve tissue engineering, the optimization of tissue properties has to be combin...
Maintenance of collagen I (Col I) and III (Col III) in a 3:1 ratio is necessary to promote cardiac h...
Maintenance of collagen I (Col I) and III (Col III) in a 3:1 ratio is necessary to promote cardiac h...
Cardiomyocytes derived from human embryonic stem cells (hESC-CMs) are regarded as promising cell sou...
The ideal scaffold for tissue engineering provides an architecture similar to natural tissue. For ca...
Activation of cardiac fibroblasts into myofibroblasts is considered to play an essential role in car...
In vitro maturation of cardiomyocytes in 3D is essential for the development of viable cardiac model...
Thesis (Ph.D.)--University of Washington, 2013Myocardial infarction (MI) causes significant cell los...
Tissue engineering approaches are currently being investigated for the restoration of myocardial fun...
Valvular heart disease is predicted to be the next cardiac epidemic (d’Arcy et al., 2011) and valve ...